A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: Properties and in vitro transfection studies

被引:177
作者
Hu, Fu-Qiang [1 ]
Zhao, Meng-Dan [1 ]
Yuan, Hong [1 ]
You, Jian [1 ]
Du, Yong-Zhong [1 ]
Zeng, Su [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310031, Peoples R China
基金
中国国家自然科学基金;
关键词
non-viral vector; chitosan oligosaccharide; micelle; transfection efficiency; Lipofectamine (TM) 2000;
D O I
10.1016/j.ijpharm.2006.02.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stearic acid (SA) grafted chitosan oligosaccharide (CSO) (CSO-SA), which was synthesized by an 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)-mediated coupling reaction, was demonstrated to form micelle like structure by self-aggregation in aqueous solution. The critical micelle concentration (CMC) of CSO-SA with 15.4% amino substituted degree of CSO was about 0.035 mg/ml. The micelles with I mg/ml CSO-SA concentration had 70.6 nm volume average hydrodynamic diameter with a narrow size distribution and 46.4 +/- 0.1 mV surface potential. Due to the cationic property, the micelles could compact the plasmid DNA to form micelle/DNA complexes nanoparticles, which can efficiently protect the condensed DNA from enzymatic degradation by DNase 1. The volume average hydrodynamic diameter of CSO-SA micelle/DNA complex increased from 203 nm to 318 nm and decreased to 102 mm due to the variation of zeta potential when the N/P ratio increased from 0.25 to 3.6 and from 3.6 to 58. The IC50 value of the CSO-SA micelle against A549 cells was 543.16 mu g/ml, while the IC50 of Lipofectamine (TM) 2000 was about 6 mu g/ml. The in vitro transfection efficiency of CSO-SA micelles was investigated by using plasmid DNA (pEGFP-C1). The transfection efficiency with CSO-SA/DNA (N/P ratio is 29) was increased with the post-transfection time (in 76 h), while the optimal transfection of Lipofectamine (TM) 2000/DNA was obtained at 24 h. The transfection of CSO-SA was not interfered in the presence of 10% fetal bovine serum, which showed remarkable enhancement effect. The optimal transfection efficiency of CSO-SA micelles in A549 cells was about 15%, which was higher than that of CSO (about 2%) and approach to that of Lipofectamine (TM) 2000 (about 20%). The low cytotoxic biodegradable CSO-SA micelles could be used as an effective DNA condensation carrier for gene delivery system. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 34 条
[11]   Polymeric gene carrier for insulin secreting cells:: Poly(L-lysine)-g-sulfonylurea for receptor mediated transfection [J].
Kang, HC ;
Kim, S ;
Lee, M ;
Bae, YH .
JOURNAL OF CONTROLLED RELEASE, 2005, 105 (1-2) :164-176
[12]   Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol) poly(L-lysine) block copolymer [J].
Katayose, S ;
Kataoka, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (02) :160-163
[13]   Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency [J].
Kean, T ;
Roth, S ;
Thanou, M .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (03) :643-653
[14]   Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates [J].
Kim, K ;
Kwon, S ;
Park, JH ;
Chung, H ;
Jeong, SY ;
Kwon, IC .
BIOMACROMOLECULES, 2005, 6 (02) :1154-1158
[15]   Optimum dose of chitin and chitosan for organization of non-woven fabric in the subcutaneous tissue [J].
Kojima, K ;
Okamoto, Y ;
Miyatake, K ;
Tamai, Y ;
Shigemasa, Y ;
Minami, S .
CARBOHYDRATE POLYMERS, 2001, 46 (03) :235-239
[16]   Non-viral gene delivery regulated by stiffness of cell adhesion substrates [J].
Kong, HJ ;
Liu, JD ;
Riddle, K ;
Matsumoto, T ;
Leach, K ;
Mooney, DJ .
NATURE MATERIALS, 2005, 4 (06) :460-464
[17]   Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid [J].
Kwon, S ;
Park, JH ;
Chung, H ;
Kwon, IC ;
Jeong, SY ;
Kim, IS .
LANGMUIR, 2003, 19 (24) :10188-10193
[18]   Preparation of chitosan self-aggregates as a gene delivery system [J].
Lee, KY ;
Kwon, IC ;
Kim, YH ;
Jo, WH ;
Jeong, SY .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :213-220
[19]   BLOOD COMPATIBILITY AND BIODEGRADABILITY OF PARTIALLY N-ACYLATED CHITOSAN DERIVATIVES [J].
LEE, KY ;
HA, WS ;
PARK, WH .
BIOMATERIALS, 1995, 16 (16) :1211-1216
[20]   Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy [J].
Mansouri, S ;
Lavigne, P ;
Corsi, K ;
Benderdour, M ;
Beaumont, E ;
Fernandes, JC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) :1-8